Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by Flooredon Oct 08, 2013 2:21pm
207 Views
Post# 21800260

RE:RE:ok

RE:RE:okI think the sky is falling... jd and DrJ are playing nice and agreeing with each other!?!?! I am new to joining this board but have been reading it for over a year as I have held this stock for about 15mos and added to my position in the last 6mos. As well, (and I am taking the liberty for speaking for others like me) I am newer to stock investing / trading and look to those like yourselves that obviously have extensive knowledge in stock investments and the biopharma space to gain a greater understanding of what is happening and why when it does. Please try and continue to 'play nice' and not belittle those who may ask questions that sound dumb to you - the only dumb questions are those that are not asked. I could prolly take a pretty solid guess that those like myself are not investing the sums of money that you and other more knowledgeable individuals are, and therefore are most likely not a threat to your final position or to the sp...so, having said that, it's ok to help us if you so desire - or share your 'secrets'. Sometimes (or many times), we may miss pieces of information that are glaringly obvious to you or unable to put all the pieces of the equation together as easily as you. Have patience with us - remember, us newbies are part of the (fingers crossed) success story too and we also have a vested interest in where this is all going. GLTA
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse